MDi‘s business model is to take an exclusive option to acquire an attractive piece of intellectual property relating to a new medical device and invest its funds to further develop the device. In return MDi will invest its own resources to develop the device to proof of concept stage. If the project meets MDi ‘s success criteria it will exercise its option to acquire the IP, develop the project further to the point where it is attractive to a Major Medical Device company and then sell or out licence it at a profit. If the project fails to meet MDi‘s success criteria it will hand the project back to the IP owner along with all the development work accomplished to date.

MDi does not manufacture, market or sell finished products. This plays to the strengths of MDi‘s management and avoids the establishment of costly infrastructure.

MDi manages a substantial portfolio of projects simultaneously and if two or more projects have commercial synergy they may be grouped together as the basis for a spin out company.

Current innovations
An image of two surgeons

MDi's latest innovations...
Case Studies and details on MDi's latest projects.

Our commitment
An image of an experiment

MDi: our commitment to you...
MDi is the first medical device development and IP management company to be established in Europe.